[Are there guidelines for timing readministration of anticoagulation with marcumar in patients with artificial heart valves after intracerebral hemorrhage (stroke, subarachnoid hemorrhage, subdural hematoma)?].
Kienast
J
J
Medizinische Klinik und Poliklinik, Abteilung Innere Medizin A, Münster.
Ringelstein
E B
EB
Borggrefe
M
M
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001780:Blood Coagulation Tests; D002543:Cerebral Hemorrhage / Q000097:blood / Q000139:chemically induced*; D006350:Heart Valve Prosthesis; D006801:Humans; D010644:Phenprocoumon / Q000008:administration & dosage / Q000009:adverse effects*; D011183:Postoperative Complications / Q000097:blood / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*; D016896:Treatment Outcome
D000925:Anticoagulants; D010644:Phenprocoumon